ERBB2 and breast cancer: An IGF-IR inhibitor was even found to enhance ErbB2-mediated apoptosis in a human breast cancer cell line with very little IGF-IR expression; evidence of this inhibitor augmenting the suppression of ErbB2 phosphorylation was also discovered [32].